responsible for the hiring, ongoing development, integration, and teamwork of eleven Vaccine Sales Professionals. Accountable for achieving sales objectives, market share and productivity objectives, and managing expense and promotional resources. Successfully launched two new vaccines, ZOSTAVAX® and GARDASIL®, and consistently ranked in the top 25% of the nation based on sales. Recipient of the 2006 and 2007 Directors award as well as the Most Valuable Peer award for the South East Region for three consecutive years. Hall of Fame recipient of the 2011, 2012, and 2018 Master's Club award for sales achievement.

responsible for overseeing fourteen sales representatives and ensuring sales objectives were met for ZOCOR®, COZAAR® / HYZAAR®, MAXALT®, and VIOXX®. Provided coaching when required and counseling when needed. Conducted monthly field visits with team members and provided coaching on a routine basis.

Professional Sales Representative responsible for achieving sales objectives and maintaining or increasing the use of assigned products through the use of business and communication skills with physicians and other health care professionals. Recipient of the 2003 Vice President's Club award as well as the Super District MVP and Senior Executive Representative's Council Leadership award.

Provided financial support for the regional Vice President and subsidiary Managing Directors. Ensured coordination of financial activities related to a variety of commercial issues such as pricing, product sourcing, buy vs. lease, local entity legal restructuring, licensing and toll manufacturing arrangements. Acted as liaison between headquarters support groups, mainly tax, legal, and manufacturing, and the subsidiaries. Ongoing duties included providing guidance and review of the region's profit plan and long range operating plan and analyzing the monthly estimates of sales and expenses.

Oversaw the Sales, Inventory, and Product Cost group which was comprised of six exempt employees. Developed the organization to handle Merck's global operations based on a geographic hierarchy. The major responsibilities included the receipt and processing of Merck's worldwide sales and inventory reports as well as global product costs. Assured the correct reserve for inter-company profit was maintained including the timely preparation of the reconciliation between Corporate and the financial reporting systems.

Primary responsibilities included performing analysis in support of projects related to capital requests, new sourcing scenarios, and proposed business restructuring. Participated as Financial Services representative on supply chain and new product planning initiatives. Monitored monthly inventory trends within the region. Audited monthly standard cost and period cost productivity as reported by the field. Participated in monthly closing process on inventory-related issues, inter-company markup elimination, and major variations from Plan.

Primary responsibilities included the consolidation of divisional results, analyzing forecasted expenditures, and coordinating the annual profit plan. Prepared the divisional operating report to include commentary on major variations from plan. Acted as liaison between corporate planning & analysis area and the division on capital projects less than $250,000 mainly related to cross border transactions between various Latin American countries and Australia.

Responsible for the tracking and elimination of inter-company profits for Merck Agricultural & Veterinary products. Prepared reconciliation and analyses of specific chemical manufacturing inventory and mechanical stores accounts on a monthly basis. Accounted for inventory movements to and from contract manufacturers, analyzed for proper matching, and recorded resulting purchase price variances.

Reported to the Assistant Divisional Controller for semi-conductors. Responsible for consolidating and reporting monthly divisional results and analyzing major variations from budget by product line. Implemented the practice of using a quantitative model for forecasting sales and gross profit by line of business. Established a new budget and cashflow process that enhanced consolidation and reporting functions utilizing Lotus 1-2-3 and IMRS’s Micro Control.

Responsible for the daily pricing of the company's various mutual funds. Compiled monthly investable cash flows by each line of business. Completely automated the consolidation and reporting of monthly activity for nine subsidiaries and joint ventures using the general ledger, an executive information system interface, and Lotus 1-2-3.

- Infantry / Air Traffic Control